Xponance’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Sell |
2,133
-1,075
| -34% | -$259K | ﹤0.01% | 940 |
|
|
2025
Q1 | $781K | Sell |
3,208
-17
| -0.5% | -$4.14K | 0.01% | 785 |
|
|
2024
Q4 | $1.06M | Buy |
3,225
+97
| +3% | +$31.9K | 0.01% | 703 |
|
|
2024
Q3 | $1.05M | Buy |
3,128
+330
| +12% | +$110K | 0.01% | 686 |
|
|
2024
Q2 | $764K | Sell |
2,798
-263
| -9% | -$71.8K | 0.01% | 769 |
|
|
2024
Q1 | $1.06M | Buy |
3,061
+327
| +12% | +$113K | 0.01% | 701 |
|
|
2023
Q4 | $883K | Sell |
2,734
-562
| -17% | -$181K | 0.01% | 719 |
|
|
2023
Q3 | $1.18M | Buy |
3,296
+135
| +4% | +$48.4K | 0.02% | 602 |
|
|
2023
Q2 | $1.2M | Buy |
3,161
+211
| +7% | +$80K | 0.02% | 607 |
|
|
2023
Q1 | $1.41M | Sell |
2,950
-9
| -0.3% | -$4.31K | 0.02% | 546 |
|
|
2022
Q4 | $1.24M | Buy |
2,959
+562
| +23% | +$236K | 0.02% | 569 |
|
|
2022
Q3 | $1M | Buy |
2,397
+312
| +15% | +$130K | 0.02% | 578 |
|
|
2022
Q2 | $1.03M | Sell |
2,085
-4,387
| -68% | -$2.17M | 0.02% | 562 |
|
|
2022
Q1 | $3.65M | Sell |
6,472
-6,376
| -50% | -$3.59M | 0.06% | 251 |
|
|
2021
Q4 | $9.71M | Buy |
12,848
+260
| +2% | +$196K | 0.15% | 115 |
|
|
2021
Q3 | $9.39M | Buy |
12,588
+7,102
| +129% | +$5.3M | 0.18% | 98 |
|
|
2021
Q2 | $3.54M | Sell |
5,486
-1,228
| -18% | -$791K | 0.07% | 243 |
|
|
2021
Q1 | $3.84M | Buy |
6,714
+1,352
| +25% | +$772K | 0.08% | 201 |
|
|
2020
Q4 | $3.13M | Buy |
5,362
+4,504
| +525% | +$2.63M | 0.07% | 235 |
|
|
2020
Q3 | $442K | Sell |
858
-34
| -4% | -$17.5K | 0.01% | 704 |
|
|
2020
Q2 | $403K | Buy |
+892
| New | +$403K | 0.01% | 702 |
|